CGEM vs NVS
Cullinan Oncology LLC (CGEM) versus NVS (NVS) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
NVS (NVS) common stock.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
NVS does not have a complete income-statement cache yet.
CGEM currently screens at market cap $830.3M. NVS currently screens at market cap $0.
Not investment advice. Open the CGEM and NVS stock pages for the full models.
Not investment advice.